News BioNTech SE Börse Stuttgart

Equities

22UA

US09075V1026

Market Closed - Börse Stuttgart Other stock markets 10:56:13 03/05/2024 pm IST			5-day change	1st Jan Change
85.95 ^EUR	+0.35%		+4.63%	-3.17%

01/05	European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading	MT
25/04	Sector Update: Health Care Stocks Drop in Afternoon Trading	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents	03/05	AQ
BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Collaborations GmbH on the domination and profit and loss transfer agreement pursuant to Section 293a AktG	03/05	PU
BioNTech : Report of the Management Board on Agenda Items 12 and 13 lit. c) and d)	03/05	PU
BioNTech : Extracts from the minutes of the Annual General Meetings of 18 August 2017, 19 August 2019, 26 June 2020 and 22 June 2021 (2017/2019 share option program and 2021 share option program)	03/05	PU
BioNTech : Report of the Management Board on Agenda Items 12 and 13 lit. c) and d)	03/05	PU
BioNTech : Report of the Management Board on Agenda Item 13	03/05	PU
BioNTech : Extracts from the minutes of the Annual General Meetings of 18 August 2017, 19 August 2019, 26 June 2020 and 22 June 2021 (2017/2019 share option program and 2021 share option program)	03/05	PU
BioNTech : Draft of the domination and profit and loss transfer agreement between BioNTech SE and BioNTech Collaborations GmbH	03/05	PU
BioNTech : Annual financial statements of BioNTech SE as of 31 December 2022	03/05	PU
BioNTech : Annual Report 2022 with the Consolidated Financial Statements as of 31 December 2022, the Combined Management Report for BioNTech SE and the Group and the Report of the Supervisory Board for the 2022 financial year	03/05	PU
BioNTech : Annual financial statements of BioNTech SE as of 31 December 2023	03/05	PU
BioNTech : Opening balance sheet of BioNTech Collaborations GmbH as of 18 March 2024	03/05	PU
BioNTech : Registration and authorization form as well as authorization and instruction form	03/05	PU
BioNTech : Invitation to the 2024 Annual General Meeting	03/05	PU
BioNTech : Information pursuant to Section 125 AktG in conjunction with Article 4 (1) and Table 3 of Implementing Regulation (EU) 2018/1212	03/05	PU
BioNTech : Annual Report 2023 with the Consolidated Financial Statements as of 31 December 2023, the Combined Management Report for BioNTech SE and the Group and the Report of the Supervisory Board for the 2023 financial year	03/05	PU
BioNTech : Annual Financial Statements as of 31 December 2023	03/05	PU
BioNTech : Proposal of the Management Board for the appropriation of the balance sheet profit for the 2023 financial year	03/05	PU
BioNTech : Compensation Report for the 2023 financial year	03/05	PU
BioNTech : Compensation system 2024 for the members of the Management Board of BioNTech SE	03/05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BIONTECH : A miss is a miss

March 21, 2024 at 06:57 pm IST